Thomas Ardiles
Critical Care Medicine · Dallas, TXNPI 1437119278
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $36,243 of the $46,729 with a category attached, or 77.6%. 31 manufacturers reported payments, led by Mylan Specialty L.p. at 31.6% of the total. Reporting peaked in 2019 at $23,388 and has fallen 99.9% since, to $27 in 2024. Among critical care medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 157 payments — averaging $297.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mylan Specialty L.p.$15K
- Grifols USA, LLC$15K
- AstraZeneca$10K
- Cook Incorporated$3K
- Grifols Shared Services North America, Inc.$1K
- Stryker$1K
- plus $2K from 25 others
Across 7 payments — averaging $1421.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Takeda Pharmaceuticals U.S.A., Inc.$10K
What the payments were for
- Consulting fees$2,2685%
- Speaking & faculty fees$36,24378%
- Travel & lodging$3,2887%
- Food & beverage$4,93111%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mylan Specialty L.p. | 31 | $14,771 |
| Grifols USA, LLC | 26 | $14,602 |
| AstraZeneca | 27 | $10,197 |
| Cook Incorporated | 1 | $2,800 |
| Grifols Shared Services North America, Inc. | 15 | $1,449 |
| Stryker | 1 | $1,000 |
| Sanofi | 7 | $341 |
| Genentech USA, Inc. | 9 | $280 |
| Regeneron Healthcare Solutions, Inc. | 5 | $158 |
| Boehringer Ingelheim | 7 | $139 |
| Abbott | 1 | $132 |
| Abiomed | 1 | $125 |
| Genentech, Inc. | 1 | $104 |
| Cook Medical LLC | 1 | $91 |
| GSK | 5 | $82 |
| Sunovion Pharmaceuticals Inc. | 4 | $64 |
| La Jolla Pharmaceutical Company | 1 | $54 |
| Getinge USA Sales, LLC | 1 | $43 |
| Baxter Healthcare | 1 | $43 |
| Octapharma USA, Inc. | 1 | $36 |
| Vapotherm Inc | 1 | $28 |
| Gilead | 1 | $27 |
| United Therapeutics Corporation | 1 | $24 |
| Shire North American Group Inc | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Advanced Respiratory, Inc | 1 | $20 |
| Merck | 1 | $18 |
| Sandoz | 1 | $16 |
| Circassia Inc. | 1 | $16 |
| Novartis | 1 | $15 |
| Bayer | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Yupelri$14,359
- FASENRA$9,766
- Prolastin-C Liquid$8,712
- Prolastin-C$5,660
- Cook Medical Ciaglia Blue Rhino$2,800
- GLIDE SYSTEM$1,000
- DUPIXENT$233
- CentriMag$132
- Impella$125
- XOLAIR$104
How this compares
$46,729 in reported general payments places this provider in the 95th percentile of 507 critical care medicine providers in Texas.
Other critical care medicine in Dallas
- Anthony OrtegonDallas$106K
- Gary WeinsteinDallas$103K
- Rebecca DoebeleDallas$12K
- Humayun AnjumDallas$11K
- Sridhar BadireddiDallas$11K
- David PhamDallas$10K
- Jake RiceDallas$9K
- Bryan KellyDallas$9K
- Munir HazbunDallas$8K
- Steven DavidoffPlano$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.